Piper Sandler Keeps Their Hold Rating on Iovance Biotherapeutics (IOVA)
In a report released today, Joseph Catanzaro from Piper Sandler maintained a Hold rating on Iovance Biotherapeutics (IOVA – Research Report), ...
Truist maintains Buy on IOVA stock with a $25 target
Truist Securities confirmed its positive stance on Iovance Biotherapeutics (NASDAQ:IOVA) shares, maintaining a Buy rating and a price target of $25.00. With the stock currently trading at $6.07, this ...
What's Wrong With Iovance Biotherapeutics Stock?
It was about a year ago that shares of Iovance Biotherapeutics (NASDAQ: IOVA) began to take off. Could this be a great buying ...
Truist Financial Releases a Buy Rating on Iovance Biotherapeutics (IOVA)
In a report released today, Asthika Goonewardene from Truist Financial assigned a Buy rating to Iovance Biotherapeutics (IOVA – Research ...
bovnews2d
Why Did Iovance Biotherapeutics Inc (IOVA) Stock Surge 5.27% Last Week?
Iovance Biotherapeutics Inc (IOVA) stock saw a decline, ending the day at $6.19 which represents a decrease of $-0.06 or -0.96% from the prior close of $6.25. The stock opened at $6.28 and touched a ...
Where Will Iovance Biotherapeutics Be in 5 Years?
Iovance Biotherapeutics (NASDAQ: IOVA), a small-cap biotech company, has an innovative approach to treating cancer that ...
Stifel maintains Buy on Iovance stock with $21 target
Stifel analysts maintained a Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA) with a steady price target of $21.00. According to InvestingPro data, the stock currently trades at $6.40, with analyst ...
bovnews4d
Why Iovance Biotherapeutics Inc (IOVA) Stock is Currently -7.05% Off from Its 20-Day SMA?
Iovance Biotherapeutics Inc (IOVA) stock saw a modest uptick, ending the day at $6.25 which represents a slight increase of $0.06 or 0.97% from the prior close of $6.19. The stock opened at $6.24 and ...